Epilepsy in women with gynecologic malignancies

References

• Saphner T, Gallion HH, Van Nagell JR, et al. Neurologic complications of cervical cancer. A review of 2261 cases. Cancer 1989;64(5):1147-51
   PubMed Web of Science ®Google Scholar
• Abrey LE, Dalmau JO. Neurologic Complications of Ovarian Carcinoma. Cancer 1999;85(1):127-33
   PubMed Web of Science ®Google Scholar
• Clouston PD, DeAngelis LM, Posner JB. The spectrum of neurological disease in patients with systemic cancer. Ann Neurol 1992;31(3):268-73
   PubMed Web of Science ®Google Scholar
• Cormio G, Lissoni A, Losa G, et al. Brain metastases from endometrial carcinoma. Gynecol Oncol 1996;61(1):40-3
   PubMed Web of Science ®Google Scholar
• Bradley P, Lindsay B. Epilepsy clinics versus general neurology or medical clinics. Cochrane Database Syst Rev 2001(1):CD001910
   Google Scholar
• Yumru AE, Bozkurt M, Ayanoğlu YT, et al. The relation between the presence of a giant primary ovarian leiomyoma and the occurrence of epilepsy as aparaneoplastic syndrome. Arch Gynecol Obstet 2010;281(3):531-4
   PubMed Web of Science ®Google Scholar
• Dalmau J, Tüzün E, Haiyan W, et al. Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis Associated with Ovarian Teratoma. Ann Neurol 2007;61(1):25-36
   PubMed Web of Science ®Google Scholar
• Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7(12):1091-8
   PubMed Web of Science ®Google Scholar
• Tanyi JL, Marsh EB, Dalmau J, Chu CS. Reversible Paraneoplastic Encephalitis in Three Patients with Ovarian Neoplasms. Acta Obstet Gynecol Scand 2012;91(5):630-4
   PubMed Web of Science ®Google Scholar
• Singh G, Rees JH, Sander JW. Seizures and epilepsy in oncological practice: causes, course, mechanisms and treatment. J Neurol Neurosurg Psychiatry 2007;78(4):342-9
   PubMed Web of Science ®Google Scholar
• Asensio N, Luis A, Costa I, et al. Meningeal Carcinomatosis and Uterine Carcinoma. Three Different Clinical Settings and Review of the Literature. Int J Gynecol Cancer 2009;19(1):168-72
   PubMed Web of Science ®Google Scholar
• Brogna C, Gil Robles S, Duffau H. Brain tumors and epilepsy. Expert Rev Neurother 2008;8(6):941-55
   PubMedGoogle Scholar
• Ogawa K, Yoshii Y, Aoki Y, et al. Treatment and prognosis of brain metastases from gynecological cancers. Neurol Med Chir (Tokyo) 2008;48(2):57-62
   PubMed Web of Science ®Google Scholar
• Khasraw M, Posner JB. Neurological complications of systemic cancer. Lancet Neurol 2010;9(12):1214-27
   PubMed Web of Science ®Google Scholar
• Nasu K, Satoh T, Nishio S, et al. Clinicopathologic features of brain metastases from gynecologic malignancies: a retrospective study of 139 cases (KCOG-G1001s trial). Gynecol Oncol 2013;128(2):198-203
   PubMed Web of Science ®Google Scholar
• Tosoni A, Ermani M, Brandes AA. The pathogenesis and treatment of brain metastases: a comprehensive review. Crit Rev Oncol Hematol 2004;52(3):199-215
   PubMed Web of Science ®Google Scholar
• Hwang JH, Yoo HJ, Lim MC, et al. Brain metastasis in patients with uterine cervical cancer. J Obstet Gynaecol Res 2013;39(1):287-91
   PubMed Web of Science ®Google Scholar
• Echlin FA. The supersensitivity of chronically "isolated" cerebral cortex as a mechanism in focal epilepsy. Electroencephalogr Clin Neurophysiol 1959;11:697-722
   PubMedGoogle Scholar
• Penfield W, Erickson TC, Tarlov I. Relation of intracranial tumours and symptomatic epilepsy. Arch NeurPsych 1940;44(2):300-15
   Google Scholar
• Righi V, Andronesi OC, Mintzopoulos D, et al. High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in braintumors. Int J Oncol 2010;36(2):301-6
   PubMed Web of Science ®Google Scholar
• Hino A, Imahori Y, Tenjin H, et al. Metabolic and hemodynamic aspects of peritumoral low-density areas in human brain tumor. Neurosurgery 1990;26(4):615-21
   PubMed Web of Science ®Google Scholar
• Hamberger A, Nystrom B, Larsson S, et al. Amino acids in the neuronal microenvironment of focal human epileptic lesions. Epilepsy Res 1991;9(1):32-43
   PubMed Web of Science ®Google Scholar
• Prakash O, Lukiw WJ, Peruzzi F, Reiss K, Musto AE. Gliomas and seizures. Med Hypotheses 2012;79(5):622-6
   PubMed Web of Science ®Google Scholar
• Bhansali A, Banerjee AK, Chanda A, et al. Radiation-induced brain disorders in patients with pituitary tumours. Australas Radiol 2004;48(3):339-46
   PubMedGoogle Scholar
• Di Stefano AL, Berzero G, Vitali P, et al. Acute late-onset encephalopathy after radiotherapy: an unusual life-threatening complication. Neurology 2013;81(11):1014-17
   PubMed Web of Science ®Google Scholar
• Lynam LM, Lyons MK, Drazkowski JF, et al. Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg 2007;109(7):634-8
   PubMed Web of Science ®Google Scholar
• Alajbegović A, Loga N, Alajbegović S, Suljić E. Characteristics of symptomatic epilepsy in patients with brain tumours. Bosn J Basic Med Sci 2009;9(1):81-4
   PubMed Web of Science ®Google Scholar
• Ramamurthi B, Ravi R, Ramachandran V. Convulsions with meningiomas: incidence and significance. Surg Neurol 1980;14(6):415-16
   PubMedGoogle Scholar
• De Santis A, Villani R, Sinisi M, et al. Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study. Epilepsia 2002;43(2):175-82
   PubMed Web of Science ®Google Scholar
• Sirven JI, Wingerchuk DM, Drazkowski JF, et al. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 2004;79(12):1489-94
   PubMed Web of Science ®Google Scholar
• Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54(10):1886-93
   PubMed Web of Science ®Google Scholar
• Upton N. Mechanisms of action of new antiepileptic drugs: rational design and serendipitous findings. Trends Pharmacol Sci 1994;15(12):456-63
   PubMed Web of Science ®Google Scholar
• van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 2007;6(5):421-30
   PubMed Web of Science ®Google Scholar
• Wagner GL, Wilms EB, Van Donselaar CA. Vecht ChJ. Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 2003;12(8):585-6
   PubMed Web of Science ®Google Scholar
• Maschio M, Albani F, Baruzzi A, et al. Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol 2006;80(1):97-100
   PubMed Web of Science ®Google Scholar
• Newton HB, Goldlust SA, Pearl D. Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients. J Neurooncol 2006;78(1):99-102
   PubMed Web of Science ®Google Scholar
• Thompson D, Takeshita J, Thompson T, Mulligan M. Selecting Antiepileptic Drugs for Symptomatic Patients With Brain Tumors. J Support Oncol 2006;4(8):411-16
   PubMedGoogle Scholar
• Cascino GD, Kelly PJ, Hirschorn KA, Marsh WR, Sharbrough FW. Stereotactic resection of intra-axial cerebral lesions in partial epilepsy. Mayo Clin Proc 1990;65(8):1053-60
   PubMed Web of Science ®Google Scholar
• Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Eng J Med 2003;349(16):1543-54
   PubMed Web of Science ®Google Scholar
• Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 2002;1(5):294-305
   PubMed Web of Science ®Google Scholar
• Rojas-Marcos I, Rousseau A, Keime-Guibert F. Spectrum of paraneoplastic neurologic disorders in women with breast and gynecologic cancer. Medicine 2003;82(3):216-23
   PubMed Web of Science ®Google Scholar
• Petit T, Janser JC, Achour NR, et al. Paraneoplastic temporal lobe epilepsy and anti-Yo autoantibody. Ann Oncol 1997;8(9):919-20
   PubMed Web of Science ®Google Scholar
• Darnell RB, Posner JB. Paraneoplastic syndromes affecting the nervous system. Semin Oncol 2006;33(3):270-98
   PubMed Web of Science ®Google Scholar
• Fan XC, Steitz JAHNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci USA 1998;163(2):159-62
   Google Scholar
• Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123(Pt 7):1481-94
   PubMed Web of Science ®Google Scholar
• Tanaka K, Tanaka M, Inuzuka T, et al. Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody. J Neurol Sci 1999;163(2):159-62
   PubMed Web of Science ®Google Scholar
• Dalmau J, Furneaux HM, Rosenblum MK, et al. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 1991;41(11):1757-64
   PubMed Web of Science ®Google Scholar
• Tanaka M, Tanaka K, Tsuji S, et al. Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration. J Neurol Sci 2001;188(1-2):61-5
   PubMed Web of Science ®Google Scholar
• Abel CG, Kochen S, Cirio JJ, Sica RE. Partial non convulsive epileptic status as initial presentation of limbic encephalitis. Rev Neurol 2001;32(8):734-7
   PubMed Web of Science ®Google Scholar
• Fadul CE, Stommel EW, Dragnew KH, et al. Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy. J neurooncol 2005;72(2):195-8
   PubMed Web of Science ®Google Scholar
• Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychatric symptoms, and hypoventilation in ovarian teratoma. Ann neurol 2005;58(4):594-604
   PubMed Web of Science ®Google Scholar
• Voutsas V, Mylonaki E, Gymnopoulos K, et al. Paraneoplastic limbic encephalitis as a cause of new onset of seizures in a patient with non-small cell lung carcinoma: a case report. J Med Case Rep 2008; doi: 10.1186/1752-1947-2-270. [Epub ahead of print]
   Google Scholar
• Kim SH, Kim HY, Im YT, et al. A case of paraneoplastic limbic encephalitis due to ovarian mature teratoma. Korean J Pediatr 2010;53(4):603-6
   Google Scholar
• Kesari S, Batchelor TT. Leptomeningeal metastases. Neurol Clin 2003;21(1):25-66
   PubMed Web of Science ®Google Scholar
• Palma JA, Fernandez-Torron R, Esteve-Belloch P, et al. Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, neuroimaging features. Clin Neurol Neurosurg 2013;115(1):19-25
   PubMed Web of Science ®Google Scholar
• Eberth CJ. Zur Entwickelung des Epithelioms (Cholesteatoms) der Pia und der Lunge. Virchows Arch 1869;49(1):51-63
   Google Scholar
• Kokkoris CP. Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid? Cancer 1983;51(1):154-60
   PubMed Web of Science ®Google Scholar
• Olson ME, Chernik NL, Posner JB. Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Arch Neurol 1974;30(2):122-37
   PubMedGoogle Scholar
• Miller E, Dy I, Herzog T. Leptomeningeal carcinomatosis from ovarian cancer. Med Oncol 2012;29(3):2010-15
   PubMed Web of Science ®Google Scholar
• Eden OB, Goldie W, Wood T, Etcubanas E. Seizures following intrathecal cytosine arabinoside in young children with acute lymphoblastic leukemia. Cancer 1978;42(1):53-8
   PubMed Web of Science ®Google Scholar
• Klein P, Haley EC, Wooten GF, VandenBerg SR. Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases. Arch Neurol 1989;46(10):1149-52
   PubMedGoogle Scholar
• Wasserstrom WR, Glass JP, Posner JB. Diagnosis of leptomeningeal metastases and treatment from solid tumors: experience with 90 patients. Cancer 1982;49(4):759-72
   PubMed Web of Science ®Google Scholar
• Herrlinger U, Förschler H, Küker W, et al. Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci 2004;223(2):167-78
   PubMed Web of Science ®Google Scholar
• Verschraegen C, Conrad CA, Hong WK. Subacute encephalopathic toxicity of cisplatin. Lung Cancer 1995;13(3):305-9
   PubMed Web of Science ®Google Scholar
• Ziske CG, Schöttker B, Gorschlüter M, et al. Acute transient encephalopathy after paclitaxel infusion: report of three cases. Ann Oncol 2002;13(4):629-31
   PubMed Web of Science ®Google Scholar
• Steeghs N, de Jongh FE, Sillevis Smitt PA, van den Bent MJ. Cisplatin-induced encephalopathy and seizures. Anticancer Drugs 2003;14(6):443-6
   PubMed Web of Science ®Google Scholar
• Muallğlu S, Koçer M, Güler N. Acute transient encephalopathy after weekly paclitaxel infusion. Med Oncol 2012;29(2):1287-9
   PubMed Web of Science ®Google Scholar
• Gangloff A, Hsueh WA, Kesner AL, et al. Estimation of paclitaxel biodistribution and uptake in human-derived xenografts In vivo with (18)F-fluoropaclitaxel. J Nucl Med 2005;46(11):1866-71
   PubMed Web of Science ®Google Scholar
• O’Connor TL, Kossoff E. Delayed seizure associated with paclitaxel–Cremophor el in a Patient with early-stage breast cancer. Pharmacotherapy 2009;29(8):993-6
   PubMed Web of Science ®Google Scholar
• McGuire WP, Rowinsky EK, Rosenshein NB, et al. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med 1989;111(4):273-9
   PubMed Web of Science ®Google Scholar
• Cronk M, Abraham R, Perrin L. Case report of a generalized seizure related to paclitaxel infusion. J Natl Cancer Inst 2004;96(6):487
   PubMedGoogle Scholar
• Elkiran ET, Altundag K, Beyazit Y, et al. Fluorouracil-induced neurotoxicity presenting with generalized tonic-clonic seizure. Ann Pharmacother 2004;38(12):2171
   PubMed Web of Science ®Google Scholar
• Pirzada NA. Ali Il, Dafer RM. Fluorouracil-induced neurotoxicity. Ann Pharmacother 2000;34(1):35-8
   PubMed Web of Science ®Google Scholar
• Akitake R, Miyamoto S, Nakamura F, et al. Early detection of 5-FU-induced acute leukoencephalopathy on diffusion-weighted MRI. Jpn J Clin Oncol 2011;41(1):121-4
   PubMed Web of Science ®Google Scholar
• Kwon KA, Kwon HC, kim MC, et al. A case of 5-fluorouracil induced encephalopathy. Cancer Res Treat 2010;42(2):118-20
   PubMed Web of Science ®Google Scholar
• Koenig H, Patel A. Biochemical basis for fluorouracil neurotoxicity. The role of Krebs cycle inhibition by fluoroacetate. Arch Neurol 1970;23(2):155-60
   PubMedGoogle Scholar
• Yeh KH, Cheng AL. High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy. Br J Cancer 1997;75(3):464-5
   PubMed Web of Science ®Google Scholar
• Butterworth RF. Neurotransmitter function in thiamine-deficiency encephalopathy. Neurochem Int 1982;4(6):449-64
   PubMedGoogle Scholar
• Keyser A, De Bruijn SF. Epileptic manifestations and vitamin B1 deficiency. Eur Neurol 1991;31(3):121-5
   PubMed Web of Science ®Google Scholar
• Cordier PY, Nau A, Ciccolini JJ, et al. 5-FU-induced neurotoxicity in cancer patients with profound DPD deficiency syndrome: a report of two cases. Cancer Chemother Pharmacol 2011;68(3):823-6
   PubMed Web of Science ®Google Scholar
• Fujiwaki R, Hata K, Nakayama K, et al. Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer. J Clin Oncol 2000;18(23):3946-51
   PubMed Web of Science ®Google Scholar
• Arunkumar P, Viswanatha G, Radheshyam N, et al. Science behind cisplatin-induced nephrotoxicity in humans: a clinical study. Asian Pac J Trop Biomed 2012;2(8):640-4
   PubMedGoogle Scholar
• Park TK, Choi DH, Kim SN, et al. Role of induction chemotherapy in invasive cervical cancer. Gynecol Oncol 1991;41(2):107-12
   PubMed Web of Science ®Google Scholar
• Lajer H, Daugaard G. Cisplatin and hypomagnesemia. Cancer Treat Rev 1999;25(1):47-58
   PubMed Web of Science ®Google Scholar
• Weisleder P, Tobin JA, Kerrigan JF, Bodensteiner JB. Hypomagnesemic Seizures: case Report and Presumed Pathophysiology. J Child Neurol 2002;17(1):59-61
   PubMed Web of Science ®Google Scholar
• Daugaard G. Cisplatin nephrotoxicity experimental and clinical studies. Dan Med Bull 1990;37(1):1-12
   PubMedGoogle Scholar
• Halawa I, Andersson T, Tomson T. Hyponatremia and risk of seizures: a retrospective cross-sectional study. Epilepsis 2011;52(2):410-13
   Google Scholar
• Conrad J, Pawlowski M, Dogan M, et al. Seizures after cerebrovascular events: risk factors and clinical features. Seizure 2013;22(4):275-82
   PubMed Web of Science ®Google Scholar
• Shamonki MI, Squatrito RC, Welander CE. Advanced ovarian carcinoma presenting with a cerebrovascular accident. Gynecol Oncol 1998;70(2):300-2
   PubMed Web of Science ®Google Scholar
• Cestari DM, Weine DM, Panageas KS, et al. Stroke in patients with cancer: incidence and etiology. Neurology 2004;62(11):2025-30
   PubMed Web of Science ®Google Scholar
• Slapø GD, Lossius MI, Gjerstad L. Poststroke epilepsy: occurrence, predictors and treatment. Expert Rev Neurother 2006;6(12):1801-9
   PubMedGoogle Scholar
• Balami JS, Buchan AM. Complications of intracerebral haemorrhage. Lancet Neurol 2012;11(1):101-18
   PubMed Web of Science ®Google Scholar
• Pruitt AA. Central nervous system infections in cancer patients. Semin Neurol 2004;24(4):435-52
   PubMed Web of Science ®Google Scholar
• Nishida T, Nagasue N. Treatment of gynecological adenocarcinomas with a combination of ifosfamide, adriamycin and cisplatin. Nihon Sanka Fujinka Gakkai Zasshi 1988;40(5):635-9
   PubMedGoogle Scholar
• Kim MA, Park KM, Kim SE, et al. Acute symptomatic seizures in CNS infection. Eur J Neurol 2008;15(1):38-41
   PubMed Web of Science ®Google Scholar
• Baffour FI. CNS inflammation and epileptogenesis. Int J Sci Eng Res 2012;3(2):5-9
   Google Scholar
• Pradhan S, Yadav R. Seizures and epilepsy in central nervous system infections. Neurology Asia 2004;9(suppl 1):4-9
   Google Scholar
• Xuefeng W. Protocol about diagnosis and treatment of adult with epilepsy. Chin J Intern Med 2006;45(10):875-7
   Google Scholar
• Seino M. Classification criteria of epileptic seizures and syndromes. Epilepsy Res 2006;70(1):27-33
   PubMedGoogle Scholar
• Gatzonis S, Triantafyllou N, Kateri M, et al. The prognostic value of electroencephalography in epilepsy: a long-term follow-up study. Neurol Int 2010;2:2- doi: 10.4081/ni.2010.e18
   Google Scholar
• Herman ST, Takeoka M, Hughes JR, Drislane FW. Electroencephalography in clinical epilepsy research. Epilepsy Behav 2011;22(1):126-33
   PubMed Web of Science ®Google Scholar
• Yap KY, Chui WK, Chan A. Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther 2008;30(8):1385-407
   PubMed Web of Science ®Google Scholar
• Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2003;2(8):473-81
   PubMed Web of Science ®Google Scholar
• Li Y, Liu T, Ivan C, et al. Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells. Front Oncol 2013;20:3- doi: 10.3389/fonc.2013.00058
   Google Scholar
• Blaheta RA, Cinatl J Jr. Anti-tumor mechanisms of valproate: a novel role for an old drug. Med Res Rev 2002;22(5):492-511
   PubMed Web of Science ®Google Scholar
• Rudà R, Magliola U, Bertero L, et al. Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro Oncol 2013;12(12):1739-49
   Google Scholar